Technical information
Manufacturer
THERATECHNOLOGIES INTERNATIONAL LIMITED
Presentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
zEk5n2PudvmAkpJp